Stay updated with breaking news from Cytoki pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Etrasimod was effective and well tolerated as an induction and maintenance therapy in patients with moderately to severely active ulcerative colitis. Etrasimod is a treatment option with a unique combination of attributes that might address the persistent unmet needs of patients with ulcerative colitis. ....